US Medical Foods Market
ID: MRFR/Pharma/12139-CR | 100 Pages | Author: Garvit Vyas| December 2023
The US Medical Foods Market size was valued USD 8,402.15 million in 2021, is poised to demonstrate a 7.07% Compound Annual Growth Rate (CAGR) during the study period. This growth is underpinned by the region's high prevalence of chronic diseases like diabetes, cancer, and neurological disorders, necessitating specialized nutritional management. Notably, the National Cancer Institute projected around 1,806,590 new cancer cases in the US in 2020, with an estimated 606,520 associated deaths. The Centers for Disease Control and Prevention reported over 133 million diabetes cases in 2022, emphasizing the demand for tailored nutrition in disease management. The surge in cancer, diabetes, and other chronic conditions highlights the need for personalized nutrition solutions, and North America's robust healthcare infrastructure further propels market expansion. Moreover, the region witnesses an increased demand for medical food products targeting conditions such as phenylketonuria (PKU) and other rare diseases. The United States Food and Drug Administration (FDA) plays a pivotal role by establishing a regulatory framework for medical foods, fostering innovation among key market players. Additionally, the growing awareness of medical food benefits and favorable reimbursement policies contribute significantly to the market's upward trajectory. The comprehensive healthcare landscape and the prevalence of chronic diseases create an environment where personalized nutritional management becomes integral. The regulatory support from the FDA ensures that innovative medical food products catering to specific health conditions can enter the market, addressing unmet needs. This, coupled with increasing awareness among consumers about the advantages of medical foods, further fuels the growth momentum. The proactive reimbursement policies further incentivize the adoption of medical food products, creating a favorable market ecosystem in North America. As the region continues to grapple with the challenges posed by chronic diseases, the demand for specialized nutritional solutions is expected to sustain the positive growth trajectory in the medical foods market.
Report Attribute/Metric | Details |
Market Size 2022 | USD 21.38 billion |
Market Size 2023 | USD 22.62 billion |
Market Size 2032 | USD 35.3 billion |
Compound Annual Growth Rate (CAGR) | 6.3% (2023-2032) |
Base Year | 2022 |
Forecast Period | 2023-2032 |
Historical Data | 2019 to 2021 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Nutritional Ingredients, Route of Administration, Form, Application, Distribution Channel, and, and Region |
Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
Countries Covered | The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled | Danone SA (France), Abbott (US), Fresenius Kabi AG (Germany), TARGETED MEDICAL PHARMA INC (US), Metagenics LLC (US), Nestlรฉ (Switzerland), Reckitt Benckiser Group PLC (UK), Medtrition, Inc (US), Primus Pharmaceuticals, Inc (US), and Alfasigma USA, Inc (US) |
Key Market Opportunities | Increasing product launch initiatives and constant innovations in developing products |
Key Market Dynamics | Increasing prevalence of chronic diseases Growing nutritional deficiency among people Raising awareness about prebiotics and probiotic products |
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
ยฉ 2024 Market Research Future ยฎ (Part of WantStats Reasearch And Media Pvt. Ltd.)